DEFA14A: Baker Hughes Director Nominee Withdraws Ahead of 2025 Annual Meeting

Ilham Kadri withdraws from Baker Hughes' Board of Directors election due to heightened executive responsibilities amid the current macroeconomic climate.

Summary

• Baker Hughes Company announced that Ilham Kadri will not stand for election as a director at the 2025 Annual Meeting of Shareholders.
• Dr. Kadri informed the Board on April 21, 2025, of her decision to withdraw due to increased commitments related to her executive responsibilities.
• The Board had initially appointed Dr. Kadri on March 28, 2025, with her term to begin on May 1, 2025.
• As a result of her withdrawal, Dr. Kadri will no longer join the Board on May 1, 2025, and the Board size will remain at nine members after the Annual Meeting.
• Shareholders who have already submitted proxies do not need to take action unless they wish to change their vote.
• Proxies with instructions to vote for Dr. Kadri will not be counted for her election but will be voted as directed on other matters.
• Shareholders who have not yet voted should disregard Dr. Kadri's name on the proxy card.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While a director nominee withdrawing is not ideal, the company states it's due to personal reasons and not disagreements.

Positives

• Dr. Kadri's decision is not due to any disagreement with the Company or its management.

Negatives

• The company must proceed with one less board member than planned.

Risks

• The withdrawal of a director nominee could potentially raise questions about the company's board composition and strategic direction, although the company states it is not due to any disagreement.

Future Outlook

The company will proceed with the Annual Meeting with one less director nominee.

Management Comments

• Dr. Kadri informed the Board on April 21, 2025 that, in light of the heightened commitments associated with her executive responsibilities amid the current macroeconomic climate, she has decided to withdraw her acceptance of her appointment to the Board.
• Dr. Kadris decision is not the result of any disagreement with the Company or its management on any matter relating to the Companys operations, policies or practices.

Industry Context

Director changes are common, but the timing of this withdrawal, so close to the annual meeting, is unusual and may raise some eyebrows in the industry.

Management Changes

Stakeholder Impact

• Shareholders need to be aware of the change in the director nominee slate.
• The Board will continue with nine members, potentially impacting its decision-making dynamics.

Next Steps

• The Annual Meeting will proceed on May 20, 2025, with nine director nominees.
• Shareholders should disregard Dr. Kadri's name when submitting their proxy votes.

Key Dates

Keywords

Baker Hughes, Board of Directors, Annual Meeting, Ilham Kadri, Proxy Statement, Director Nomination, Withdrawal